Application note: Cellartis® Power™ Primary HEP Medium – extend functionality of your primary hepatocytes to 4 weeks
Posted: 7 June 2018 | Takara Bio | No comments yet
Human primary hepatocytes (hphep cells) are the gold standard for in vitro evaluation of drug metabolism, drug-drug interactions, safety assessment of drug candidates, and disease modeling.
However, a significant limitation of hphep cells is their rapid loss of function when cultured in vitro. To enable long-term cultures of primary hepatocytes in user-friendly 2D-culture formats, we developed Cellartis Power Primary HEP Medium (Power HEP medium), a new medium that maintains healthy, functional human primary hepatocytes for up to four weeks in conventional 2D cultures – without the need of overlays or sandwich cultures – overcoming a key limitation of hphep cells. Furthermore, the recommended culture schedule is weekend-free, requiring media changes only on Mondays, Wednesdays, and Fridays.
This application note is restricted - login or subscribe free to access
Why subscribe? Join our growing community of thousands of industry professionals and gain access to:
- quarterly issues in print and/or digital format
- case studies, whitepapers, webinars and industry-leading content
- breaking news and features
- our extensive online archive of thousands of articles and years of past issues
- ...And it's all free!
Click here to Subscribe today Login here
Related content from this organisation
- ebook: Current and emerging strategies for engineered cell therapies: cancer immunotherapy
- Providing new hope for rare disease using non-viral gene therapy
- The promise of cell therapy: scaling up a new treatment paradigm for hearing loss
- Challenges and opportunities: lessons learned in developing potential gene therapy cures
- Leveraging a dual technology platform to develop gene therapies for a range of rare diseases
Related topics
Cell Cultures, Drug Discovery, Drug Discovery Processes, Stem Cells
Related organisations
Takara Bio